Human submandibular/sublingual gland secretions contain a multimeric high molecular weight mucin (MG1) and a monomeric low molecular weight mucin (MG2). MG2 is the product of the MUC7 gene, whereas the gene for MG1 has not been identified. Previously, we isolated a clone (pSM2-l) from a human sublingual gland cDNA expression library using an antibody against deglycosylated MG1 (Troxler et al, Biochem. Biophys. Res Commun., 217,1112-1119,1995). In order to identify the mucin gene from which pPM2-l was derived, Northern blots of human submandibular and sublingual gland RNA were hybridized with a series of probes for tandem repeats found in the high molecular weight secreted mucins MUC2, MUC3, MUC4, MUC5AC, MUC5B, and MUC6. The only known mucin expressed at high levels in sublingual gland was MUC5B, and no known mucin was expressed at high levels in submandibular gland. A series of overlapping clones was obtained by rescreening the sublingual gland cDNA library and by reverse transcriptase-polymerase chain reaction. The resulting clones connected pSM2-l to a series of MUC5B tandem repeats at the 3' end of the repeat domain and provided the complete nudeotide and deduced amino sequence of the carboxyl terminal region of MG1. This region is enriched with respect to cysteine (-10 mol %) and contained a D domain and a carboxyl terminal domain that could be aligned with the corresponding domains in human intestinal MUC2, human tracheobronchial MUC5AC, and human von Willebrand factor. The limited expression of known mucin genes, together with the considerable mucin synthesizing capacity of submandibular gland, suggests that a novel (previously not described) mucin gene is expressed in this gland and constitutes a portion of MG1 in salivary secretions.
Introduction
Salivary mucins are important contributors to the lubricative and rheological properties of whole saliva and thus play a critical role in physiological processes such as mastication, swallowing and speech (Cohen and Levine, 1989) . Mucins are constituents of the biofilm covering both hard and soft tissues in the oral cavity providing protection from mechanical or chemical injury and from microbial assault (Mandel, 1987; Scannapieco and Levine, 1993; Tabak, 1995) . Mucins are secreted predominantly by a pair of submandibular glands, located medial to and partially under the mandible, and a pair of sublingual glands, located anterior to the submandibular glands under the tongue and beneath the mucous membrane of the floor of the mouth. The larger submandibular gland is a "mixed" gland containing both mucous and serous acini whereas the smaller sublingual gland is referred to as a "mucous" gland comprised almost entirely of mucous acini (Ten Cate, 1994) . Both glands originate from budding of buccal epithelium in early development and are functionally classified as exocrine glands. Mucins are also produced to a much lesser extent by minor salivary glands (labial, buccal, and palatine) distributed throughout the submucosa in the oral cavity. Two distinct mucins, named mucous glycoprotein 1 (MG1) and mucous glycoprotein 2 (MG2), have been isolated and partially characterized with respect to their biochemical and functional properties (Levine et al., 1987; Loomis et al., 1987; Cohen and Levine, 1989; Scannapieco and Levine, 1993) . These mucins were isolated from secretion collected at the orifice of Wharton's duct located on the frenulum of the tongue. Since this secretion is derived from both submandibular and sublingual glands, there is no way a priori to determine whether these mucins are secreted by submandibular gland, sublingual gland, or both. MG1 is a large multimeric glycoprotein with an apparent molecular weight greater than 40 million, comprised of subunit monomers of approximately 3 x 10 6 Da with a composition of 15% protein, 78% carbohydrate, and 7% sulfate (Levine et al., 1987; Cohen and Levine, 1989) . MG2 is a small monomeric glycoprotein with an apparent molecular weight of about 1.5 x 10 5 Da, with the composition of 30% protein, 68% carbohydrate, and 1.6% sulfate (Levine et al., 1987; Reddy et al., 1992) . MG2 is the first salivary mucin for which the complete nucleotide sequence and structural organization has been determined. Sequence analysis of MG2 clones isolated from a human submandibular gland cDNA library revealed that this mucin, named MUC7, consisted of 377 amino acids (Bobek et al., 1993) . The primary sequence contains a 20 residue signal peptide, a 144 residue N-terminal domain, six nearly identical 23 amino acid tandem repeats, and a 75 residue carboxyl terminal domain. MG2 contains two cysteine residues located within the amino terminal domain, and these are thought to be involved in intramolecular disulfide bond formation, consistent with the monomeric nature of this mucin. In situ hybridization experiments and analysis of a human-hamster somatic cell hybrid panel localized MUC7 to chromosome 4q 13-21 (Bobek et al, 1996) .
Recently, we reported the first nucleotide sequence data on human salivary mucin MG1. Clones were isolated from a human sublingual gland cDNA expression library screened with an antiserum directed against deglycosylated MG1 (Troxler et al, 1995) . One clone exhibited significant sequence similarity to the ' 'extreme carboxyl terminal domain'' of human intestinal mucin MUC2 (Gum et al, 1992) , human tracheobronchial mucin MUC5AC (Meerzaman et al., 1994; Lesuffluer et al, 1995) , and human von Willebrand factor (Titani et al, 1986; Sadler, 1991) . The extreme carboxyl-terminal domain of these proteins is enriched with respect to cysteine residues (-10%), and it has been suggested that this domain is involved in intermolecular disulfide bond formation leading to polymerization of mucin and von Willebrand factor monomers (Voorberg et al, 1991; Strous and Dekker, 1992) . It is well recognized that epithelial cells Lining the gastrointestinal tract, respiratory tree, and genitourinary system express genes for two or more high molecular weight mucins. This raised the question as to whether MG1 in salivary secretions is the product of more than one mucin gene and whether genes encoding MG1 are differentially expressed in human salivary glands. The purpose of the present investigation was to identify the mucin gene or genes encoding MG1 and to determine whether these genes are expressed in both submandibular and sublingual glands.
Results

Tissue distribution of mucin mRNAs
High molecular weight mucins cannot be distinguished from one another by standard biochemical techniques due to the high density of O-glycans in the threonine/serine rich central domain of the protein core. However, all known mucins contain a variable number of unique tandem repeats ranging in size from 8-169 amino acid residues (reviewed in Gendler and Spicer, 1995; van Klinken et al, 1995) . DNA probes encoding these tandem repeats do not cross-hybridize and can be used to identify specific mRNA transcripts of a given mucin.
Northern blots of RNA from human sublingual gland, submandibular gland, trachea, stomach and small intestine were hybridized with MUC2-6 tandem repeat probes (see Materials and methods). MUC2 and MUC3 transcripts were detected at high levels in RNA from intestine but not in RNA from salivary gland, trachea, or stomach ( Figure 1A ,B). MUC4 transcripts were abundant in RNA from trachea but were not detectable in RNA from stomach and small intestine ( Figure 1C ). The MUC4 probe generated a very weak hybridization signal with RNA from both sublingual and submandibular gland, which suggests that MUC4 may be a minor component of MG1.
MUC5AC transcripts were detected at high levels in trachea and stomach RNA but not in RNA from small intestine or either salivary gland ( Figure ID) . MUC5B transcripts were abundant in RNA from sublingual gland and trachea and were also present, but to a much lesser extent, in RNA from submandibular gland ( Figure IE) . Finally, MUC6 transcripts were present at high levels in RNA from stomach but not in RNA from any of the other tissues examined ( Figure IF) . When an identical Northern blot was hybridized with a control probe for glyceraldehyde-3-phosphate dehydrogenase (GAPDH), a discrete 1.3 kb mRNA species was seen in all lanes ( Figure 1G) . It should be noted that the polydisperse hybridization signal (ranging in size from 9 kb to less than 0.5 kb) observed with all tandem repeat mucin probes is typical of the appearance of high molecular weight mucin mRNAs on Northern blots (Gum, 1992; Strous and Dekker, 1992) . The exact explanation for this hybridization pattern is not completely understood but could result from premature degradation of large mRNAs, rapid turnover of mRNAs or heterogeneity of mRNAs produced in different cells within a given tissue (Gum, 1992) . In addition, the strong hybridization signal of MUC2 and MUC3 in RNA from intestine, MUC4 in trachea, MUC5AC in trachea and stomach, MUC5B in trachea, and MUC6 in stomach is consistent with the known tissue distribution of these mucins (Gum, 1992; Gendler and Spicer, 1995; van Klinken et al, 1995) . In conclusion, the results of Northern blotting experiments provide strong evidence that MUC5B is a major component of MG1 synthesized in sublingual gland but does not appear to be a major constituent of MG1 synthesized in submandibular gland. Finally, the presence of low levels of MUC4 transcripts in RNA from both sublingual and submandibular glands ( Human subllngual gland mucin 1C) indicates that MG1 isolated from glandular secretions is the product of more than one mucin gene.
Nucleotide and deduced amino acid sequence of the C-terminal region ofMGl
The Northern blotting experiments described above suggest that MUC5B is a major mucin secreted by human sublingual gland and that it may be a principal mucin gene product comprising salivary mucin MG1. In an earlier report (Troxler et al., 1995) , screening a human sublingual gland cDNA library with a polyclonal antibody against deglycosylated MG1 identified a clone, pSM2-l, which contained an open reading frame that could be aligned with the extreme carboxyl terminal domain of MUC2 and MUC5AC, the only secreted human mucins for which the carboxyl terminal sequence was known. In order to determine whether pSM2-l represents the carboxyl terminal region of MUC5B, or that of another mucin, a series of overlapping clones was isolated from a human sublingual gland cDNA library or prepared by reverse transcriptase-polymerase chain reaction (RT-PCR) from sublingual gland RNA. These clones are shown schematically in Figure 2 . The human sublingual gland cDNA library was rescreened with the anti-MGl polyclonal antibody in attempt to identify clones containing MUC5B tandem repeats. Analysis of 500,000 PFU yielded six immunoreactive clones, which were plaque purified and sequenced. Three of these clones had inserts contained within pSM2-l, one clone contained an open reading frame that could be aligned with a D-domain in the amino terminal region of MUC2 and von Willebrand factor, and one clone contained an open reading frame that could not be aligned with any known mucin. These five clones were not further investigated. The remaining clone, pHSL77, consisted of 951 bp ( Figure 3 , nucleotides 505-1482) containing an open reading frame that could be aligned with a portion of the D4 domain in the carboxyl-terminal region of MUC2 (Gum et al, 1992) , MUC5AC (Meerzaman et al, 1994; Lesuffleur et al, 1995) , and von Willebrand factor (Titani et al., 1986) . In order to show that clones pSM2-l and pHSL77 represent portions of the same mucin, RT-PCR was carried out with sense primer CT3 ( pHSL77 and a 120 bp overlap with the 5' end of pSM2-l ( Figure 2 ; Figure 3 , nucleotides 1429-2172). This established that pHSL77 and pSM2-l represent portions of the same mucin. Since Northern blotting studies showed that MUC5B was the only known mucin to be expressed at a high level in human sublingual gland, it seemed likely that the sequence shown in Figure 3 actually represents the carboxyl-terminal region of MUC5B. Therefore, RT-PCR was carried out using a sense primer, CT1 ( Figure 3 , nucleotides 1-19) coding for a conserved sequence in MUC5B tandem repeats and antisense primer, CT2 (Figure 3 ; nucleotides 826-846) located within pHSL77. The major PCR product was cloned into pCR II to generate clone pHSL104 which contained an 846 bp insert ( Figure 2 ; Figure 3 , nucleotide 1-846). Three degenerate MUC5B tandem repeats were located at the 5' end ( Figure 3 ; nucleotides 1-225; Ser residues at start of repeats are underlined) and provided a 342 bp overlap with the 5' end of pHSL77. The consensus MUC5B tandem repeat obtained in this clone was SSTLGTAHTPAVLTTMATMPTATASTVPS, which is identical in 20 of 29 positions to the MUC5B tandem repeat consensus sequence described by Dufosse et al. (1993) . This establishes conclusively that the MG1 clone, pSM2-l, described previously (Troxler et al, 1995) , encodes the carboxyl terminal region of a mucin also containing MUC5B tandem repeats.
Analysis of the carboxyl-terminal region ofMGl
Structural analysis of the carboxyl-terminal region of MG1 revealed several notable features. The region following the MUC5B tandem repeats (Figure 3 ; residue 76-879) has a calculated molecular weight of 86,482 and a theoretical pi of 5.30 and contains 85 cysteine residues (10.6 mol %). After introduction of a number of small gaps, the position of cysteine residues in MG1 could be aligned with cysteine residues in the carboxyl-terminal regions of MUC2 (Gum et al, 1992) , MUC5AC (Meerzaman et al., 1994; Lesuffleur et al., 1995) and von Willebrand factor (Titani et al, 1986 ) (alignment not shown). The sequence similarity between the cysteine-rich regions of MG1 and either MUC2 or MUC5AC is 33% and between MG1 and von Willebrand factor is 27%. This region of MG1 contains 16 potential N-glycosylation sites with the sequence Asn-X-SerAThr (Figure 3 , asterisks), which is comparable to the 18 such sites in this region of MUC2 (Gum et al, 1992) and the 11 such sites in this region of MUC5AC (Meerzaman et al, 1994; Lesuffleur et al., 1995) . Secondary structure analyses (Chou and Fasman, 1979) of the carboxyl terminal region of MG1 predicted 92% random structure and 8% ordered structure which included four short a-helical segments (residues 234-242, 258-269, 424-^34, 463-471) and three short segments of ^-pleated sheet (residue 277-283, 307-217, 792-800). The lack of significant ordered structure in the carboxyl terminal region together with the multimeric nature of MG1, is in agreement with electron microscopic studies showing that gastric and tracheobronchial mucins can exist as extended rod-shaped molecules up to 1000 nm in length (Sheehan et al, 1986) . The hydropathicity profile of this region of MG1 (Kyte and Doolittle, 1982) showed a pattern of alternating hydrophobic and hydrophilic segments with the most hydrophobic region occurring from residue 280-320 (Figure 4 ). This region is immediately followed by a very hydrophilic region (residue 350-370). The most hydrophilic segment occurs in a short stretch of amino acids centered at residue 850, near the end of the extreme carboxyl-terminal domain. It is of interest that the most hydrophilic region of von Willebrand factor also occurs in this region of the extreme carboxyl terminal domain (Titani et aL, 1986) .
Discussion
The present investigation is the first to systematically evaluate the expression of genes for known high molecular weight secreted mucins in both human sublingual and submandibular glands. High levels of MUC5B transcripts were detected in RNA from sublingual gland, whereas this gland contained only low levels of MUC4 transcripts and no MUC2, MUC3, MUC5AC, and MUC6 transcripts. By contrast, human submandibular gland did not express high levels of mRNA for any known mucin. This gland expressed only low levels of MUC5B and MUC4 and did not express MUC2, MUC3, MUC5AC, or MUC6 at detectable levels. Thus, MUC5B is the only known high molecular weight mucin expressed at significant levels in the mucous secreting major salivary glands. In addition to the results of Northern analyses showing that MUC5B mRNA was highly expressed in sublingual gland, we obtained further evidence to suggest that the salivary mucin MG1, previously characterized only as a biochemical entity, is encoded to a significant extent by the MUC5B gene. In the present study, the complete nucleoride sequence of the carboxyl-terminal region of MG1 from sublingual gland was determined and this region was shown to be connected to MUC5B tandem repeats (Figure 3) . The fact that clones pSM2-l and pHSL77 were isolated from a sublingual gland cDNA expression library with an antibody against deglycosylated MG1 shows that the mucin depicted in Figure 3 is indeed expressed. Since clones pSM2-l and pHSL77 are part of the same mucin that contains MUC5B tandem repeats, it seems likely that the hybridization signal seen on the Northern blot of sublingual gland RNA ( Figure IE) represents a MUC5B gene product synthesized and secreted by sublingual gland. To our knowledge, the only study to identify transcripts of any known high molecular weight secreted mucin gene in salivary glands is based on in situ hybridization experiments (Audie et aL, 1993) . A 48 base oligonucleotide probe coding for a portion of a degenerate MUC5B tandem repeat was found to hybridize with intermediate intensity to RNA transcripts in two "submaxillary gland" surgical specimens. Probes for MUC2, MUC3, MUC4, and MUC5AC did not hybridize to mRNAs in these specimens. Assuming the tissue samples were in fact derived from submandibular gland, the in situ hybridization results of Audie et al. (1993) are in complete agreement with the Northern blotting experiments (Figure 1 ) and MG1 cloning studies ( Figure 3 ) described in the present work. MG1 (MUC5B) shares many of the structural features of other high molecular weight secreted mucins that have been characterized previously (Gum, 1992; Gendler and Spicer, 1995) . The polypeptide chain of MGl contains approximately 5000 amino acids and is organized into three major structural entities: (1) a cysteine-rich amino-terminal region, (2) a central tandem repeat domain, and (3) a cysteine-rich carboxyl-terminal region ( Figure 5A ). In the present study, the nucleotide and deduced amino acid sequence of the last three tandem repeats of the central domain and the entire carboxyl-terminal region have been characterized. The sequence of this portion of MGl contains three 20-29 residue degenerate MUC5B-type tandem repeats (Figure 3 , residue 1-75) followed by an 804 residue cysteine-rich region (Figure 3, residue 76-879) . The deduced sequence of this region is nearly identical to the carboxylterminal region of a recently described human gall bladder mucin, which also contains MUC5B tandem repeats (Keates et aL, 1997) . The cysteine residues in the carboxyl-terminal 150 amino acids of MGl can be almost perfectly aligned with cysteine residues in the extreme carboxyl terminal domain of MUC2 (Gum et aL, 1992) , MUC5AC (Meerzaman et aL, 1994) , von Willebrand factor (Titani et aL, 1986) , bovine submaxillary mucin (Bhargava et aL, 1990) , porcine submaxillary mucin (Eckhardt et aL, 1991) , and frog integumentary mucin Bl (Hoffman and Hauser, 1993) . It is of interest that the extreme carboxyl domain MGl and the other above mentioned proteins contains a predicted structural motif known as a ' 'cystine knot'' similar to that found in TGFf} and related growth factors (Sun and Davies, 1995) as well as in Nome disease protein (Meitinger et al., 1993) . The cystine knot is a higher order structure formed by three pairs of disulfide linked cysteine residues with an internal free cysteine that has been implicated in the formation of homo-and heterodimers (Meitinger et aL, 1993) . This motif in MGl occurs between residues 791 to 875 (Figure 3) . Based on alignment of cysteines the cystine knot could potentially involve intramolecular disulfide bonding between Cys791-Cys838, Cys814-Cys868, and Cys818-Cys870, with Cys 837 free to form a disulfide bond with another MGl monomer. Further evidence for the involvement of the extreme carboxyl terminal domain in dimerization is based on expression studies showing that recombinant polypeptides containing the extreme carboxyl terminal domain of both porcine submaxillary mucin and von Willebrand factor form disulfide linked dimers (Voorberg et al., 1991; PerezVilar et aL, 1996) . In addition, MGl contains a 395 residue cysteine-rich D4 domain (Figure 3 , residues 205-600) which can be aligned with the D4 domains of MUC2 (Gum et aL, , 1997) and was shown to comprise four "super-repeats," one of which is depicted. Each super-repeat contains a region of imperfectly conserved 29 residue tandem repeats (black bar), an "R-end subdomain" (white bar), and a small cysteine-rich subdomain (stippled bar). The structural features of the carboxyl-terminal cysteine-rich region of MGl described in this work consist of a cysteine-rich D domain (stippled bar) flanked by other cysteine-rich regions (white bars) and followed by a cystine knot (checkered bar). The schematic of MG2 in (B) shows the amino-and carboxyl-terminal regions (white bars) which flank the central tandem repeat domain consisting of six 23 residue tandem repeats (black bar) (Bobek et aL, 1993) . The ami no-terminal region contains only two cysteine residues (CC). Several potential N-linked glycosylation sites are found in both the amino-and carboxyl-terminal regions (CHO).
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1992), MUC5AC (Meerzaman et al, 1994; Lesuffleur et al, 1995) , and von Willebrand factor (Titani et al, 1986) . This domain occurs between the MUC5B repeats and the extreme carboxyl terminal domain (Figure 3 ). The low molecular weight salivary mucin MG2 (MUC7) contains only two cysteine residues in the amino-terminal region and no cysteine residues in the carboxyl-terminal region ( Figure 5B ), and this mucin does not contain the structural motifs found in MG1 and other high molecular weight secreted mucins.
The present investigation has also demonstrated that MG1 is actually a heterogeneous mixture of two or more mucin gene products. Sublingual gland contains high levels of MUC5B transcripts and low levels MUC4 transcripts (Figure 1) . In contrast, submandibular gland contains low levels of MUC5B and MUC4 transcripts. That the high molecular weight mucin in salivary secretions is indeed a mixture of different mucin gene products is supported by the finding that subpopulations of MG1 displayed differential reactivity to the lectins, MAA from Maackia amurensis and SNA from Sambucus nigra, and to monoclonal antibodies against MG1 (Bolscher et al, 1995) . In addition, immunohistochemical studies showed that a carbohydrate reactive anti-MGl monoclonal antibody reacted with some but not all mucus acini in human submandibular gland (Cohen et al, 1990) . These results are consistent with the overall heterogeneity of MG1 in salivary secretions (Bolscher et al, 1995) and the expression of more than one mucin gene in salivary glands (Figure 1) .
One of the most striking findings in the present investigation is the surprisingly large difference in the expression level of MUC5B in human sublingual and submandibular gland ( Figure  IE) . Interestingly, a similar difference in the expression pattern of the low molecular weight mucin, MUC7 (i.e., MG2) in salivary glands has also been described previously (Reddy et al, 1992; Bobek et al, 1993) . The low levels of MUC7 and MUC5B expression in submandibular (versus sublingual) gland tissue samples obtained by different investigators is unlikely to occur by chance. In addition, the observed differential expression of mucin genes is not likely to result from the capacity of sublingual and submandibular glands to synthesize mucins. First, it is known that sublingual glands are primarily mucous in nature and contain more than 95% mucous acini whereas submandibular glands are mixed and contain approximately 30-40% mucous acini and 60-70% serous acini. Second, the submandibular gland weighs 10-15 g and the sublingual gland weighs approximately 1-2 g in adult humans (Ten Cate, 1994) . Therefore, the fact that the submandibular gland contains 30-40% mucous acini and weighs 7-10 times more than the sublingual gland, which contains 95% mucous acini, means theoretically that the mucin synthesizing capacity of submandibular gland is 1.5-5 times greater than of sublingual gland. This mucin synthesizing potential is far greater than that suggested by the extremely low levels of MUC5B mRNA detected in submandibular gland by Northern analysis ( Figure  IE) . Consequently, there is almost certainly a novel (previously not identified) high molecular weight mucin gene expressed in submandibular gland and possibly in sublingual gland as well. lated by the acid phenol guanidinium thiocyanate method (Chomczynski and Sacchi, 1987) . RNA from human small intestine, stomach and trachea was obtained from Clontech (Palo Alto, CA). Mucin probes A MUC2 tandem repeat clone was kindly provided by Drs. Y. S. Kim and i. R. Gum (University of Califomia-San Francisco). Clones coding for MUC3, MUC5AC, MUC5B, and MUC6 tandem repeats were isolated from a human gallbladder cDNA library (Keates et al, 1997) . A MUC4 tandem repeat probe was generated by RT-PCR from human trachea RNA using a sense primer (5' TCAGTATCCACAGCCACCTCT 3') and an antisense primer (5' GGAAAG-GCTGGTGACATGAAG 3') designed on the basis of the published sequence (Porchet et al, 1991) . The MUC4 PCR product was ligated into pCR II (Invitrogen, San Diego, CA) and used to transform Escherichia coli INVaF'. A control probe for human GAPDH was prepared by RT-PCR from human sublingual gland RNA using specific sense (5' CTGGCGCTGAGTACGTC-GTGGAGT) and antisense (5' GACTGTGGTCATGAGTCCTTCCACG) primers (Arcari et al, 1984) . The 0.3 kb GAPDH PCR product was ligated into pCR D and cloned as described above. All probes were generated by digestion of plasmids with the appropriate restriction enzymes and labeled with a-32 PdCTP and random primers (Feinberg and Vogelstein, 1984) .
Northern blotting
RNA samples (10 jig) were electrophoresed on 1% agarose denaturing gels in lx MOPS (20 mM 3-N-morpholine-propanesulfonic acid, 5 mM sodium acetate, 1 mM EDTA) and transferred in lOx SSC (lx SSC = 0.15 M NaCl, 0.015 M sodium citrate) to nylon membrane (Hybond N+; Amersham, Chicago, IL) by capillary blotting. RNA was fixed to nylon membranes by baking al 80°C for 2 h. Blots were prehybridized in a solution containing 25 mM potassium phosphate, pH 7.4, 5x SSC, 5x Denhardt's solution (lx Denhardt's = 0.02% ficoll 40, 0.02% polyvinyl pyrrolidone, 0.02% bovine serum albumin), 0.1% SDS, 50% fonnamide, and 100 jig/ml denatured salmon sperm DNA at 42°C for 3 h. Blots were hybridized in the same solution containing 10% dextran sulfate and labeled probes at 42°C for 18 h. Final wash conditions were 0.25x SSC, 0.1% SDS at 42°C for 30 min. Blots were exposed to Kodak XAR-5 film for 4-20 h at -80°C.
cDNA library screening
The preparation of a human sublingual gland cDNA library in X-ZAP II has been described previously (Troxler et al, 1995) . Library filters were blocked with 5% nonfat dry milk in TBST (20 mM Tris-HCl, pH 8.0, 0.15 M NaCl, 0.05% Tween 20), incubated with the polyclonal antibody directed against deglycosylated MG1 (1:1000 dilution) in 5% milk in TBST, washed three times in the same buffer, and incubated with alkaline phosphatase conjugated goat anti-rabbit IgG (1:7500; Promega, Madison, WT). Color was developed with BCIP (5-bromo-4-chloro-3-indolyl phosphate) and NBT (nitro blue tetrazolium). Positive clones were plaque purified, phagemids were recovered according to manufacturers protocols (Stratagene, La Jolla, CA), and pBluescript SK-plasmids were isolated from selected colonies for sequence analysis.
DNA sequencing
In earlier experiments, DNA was sequenced by the dideoxy method with Sequenase v. 2.0 (Amersham) and either universal or sequence specific primers. In later experiments, sequencing reactions were analyzed on a Perkin Elmer-Applied Biosystems 373A automated sequencer. Nucleotide and deduced amino »cid sequences were compared to those in GenBank and the Protein Identification Resource (PIR) data base. RT-PCR human sublingual gland cDNA was synthesized in a 20 jil reaction containing 50 mM Tris-HCl, pH 8.3, 40 mM KC1, 5 mM MgCl 2 , 1 mM dithiothreitol, RNA (2 (ig), 1 mM dNTPs, RNasin (10 units), random hexamers (50 pmol), and M-MLV reverse transcriptase (400 units; Gibco-BRL, Gaithersburg, MD). The resulting cDNA was amplified in a standard 50 \>X PCR reaction using the following sequence specific primer pairs. Sense primer CT1, 5' TCCTCCACTCCAGGAACAGC, and antisense primer CT2, 5' GACAGTGAGGACGATATCCAT; or sense primer CT3, 5' TGCAGTGACTGGCGAGGTGCAA,and antisense primer CT4, 5' GCAGGCGGTCTGGACGCA. PCR products were ligated into pCR II and the recombinant plasmids were used to transform E.coli INVaF'.
Materials and methods
RNA isolation
Human submandibular and sublingual gland tissue was obtained from the National Disease Research Interchange (Philadelphia, PA) and RNA was iso-
